Insider Transactions in Q2 2025 at Silverback Therapeutics, Inc. (SBTX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2025
|
Eric Karas Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-66.09%
|
$240,000
$16.0 P/Share
|
|
Jun 18
2025
|
Eric Karas Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+39.79%
|
$15,000
$1.5 P/Share
|
|
May 20
2025
|
Kathleen D. Scott Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
50,000
-87.07%
|
$700,000
$14.1 P/Share
|
|
May 20
2025
|
Kathleen D. Scott Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+46.54%
|
$50,000
$1.5 P/Share
|
|
May 20
2025
|
Brent L Saunders |
SELL
Open market or private sale
|
Direct |
120,000
-100.0%
|
$1,680,000
$14.25 P/Share
|
|
May 20
2025
|
Brent L Saunders |
BUY
Exercise of conversion of derivative security
|
Direct |
120,000
+50.0%
|
$120,000
$1.01 P/Share
|
|
May 20
2025
|
Alexander A Fitzpatrick Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
102,969
-53.47%
|
$1,441,566
$14.1 P/Share
|
|
May 20
2025
|
Alexander A Fitzpatrick Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+34.18%
|
$500,000
$5.58 P/Share
|
|
Apr 07
2025
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
50,002
-19.21%
|
$600,024
$12.3 P/Share
|
|
Apr 07
2025
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
50,002
+9.18%
|
$200,008
$4.85 P/Share
|